Mortality of diabetic patients treated with metformin or sulphonylurea compared to persons without diabetes

被引:0
|
作者
Jecht, M. [1 ]
机构
[1] Med Klin Diabetol, D-14089 Berlin, Germany
来源
DIABETOLOGE | 2014年 / 10卷 / 08期
关键词
ALL-CAUSE; RISK; MONOTHERAPY; ASSOCIATION;
D O I
10.1007/s11428-014-1312-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:656 / 657
页数:2
相关论文
共 50 条
  • [1] Mortality of diabetic patients treated with metformin or sulphonylurea compared to persons without diabetes [Mortalität bei Diabetespatienten unter Metformin- oder Sulfonylharnstofftherapie und bei Personen ohne Diabetes]
    Jecht M.
    [J]. Der Diabetologe, 2014, 10 (8): : 656 - 657
  • [2] PATIENTS TREATED WITH INSULIN AND SULPHONYLUREA ARE AT INCREASED MORTALITY RISK AS COMPARED WITH THOSE TREATED WITH INSULIN PLUS METFORMIN
    Ioacara, S.
    Gujao, C.
    Georgescu, O.
    Martin, S.
    Sirbu, A.
    Purcaru, M.
    Fica, S.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (03) : 329 - 333
  • [3] Monotherapy with sulphonylurea is associated with increased mortality as compared with metformin in type 2 diabetes
    Mintici, L.
    Ioacara, S.
    Guja, C.
    Stegaru, D.
    Reghina, A.
    Georgescu, O.
    Martin, S.
    Purcaru, M.
    Fica, S.
    [J]. DIABETOLOGIA, 2016, 59 : S355 - S355
  • [4] Cancer mortality among Danish diabetic patients compared to patients without diabetes
    Ranc, K.
    Jorgensen, M. E.
    Witte, D. R.
    Carstensen, B.
    [J]. DIABETOLOGIA, 2012, 55 : S286 - S287
  • [5] Increased mortality in type 2 diabetes patients using sulphonylurea and metformin in combination
    Melander, A
    Olsson, J
    Lindberg, G
    [J]. DIABETOLOGIA, 1999, 42 : A3 - A3
  • [6] Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France
    Vexiau, P.
    Mavros, P.
    Krishnarajah, G.
    Lyu, R.
    Yin, D.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 : 16 - 24
  • [7] Metformin exposure in diabetic subjects is similar to patients without diabetes
    Sundelin, E. I. O.
    Gormsen, L. C.
    Heeboll, S.
    Vendelbo, M. H.
    Pedersen, S. B.
    Jakobsen, S.
    Frokiaer, J.
    Gronbaek, H.
    Jessen, N.
    [J]. DIABETOLOGIA, 2017, 60 : S421 - S422
  • [8] Counterregulatory responses to hypoglycaemia do not differ in subjects with type 2 diabetes mellitus treated with metformin compared to those treated with insulin or sulphonylurea
    Hoashi, S
    Cannon, DE
    Kilbane, MT
    Wade, BM
    Kinsley, BT
    [J]. DIABETES, 2002, 51 : A491 - A491
  • [9] All-cause mortality in patients on sulphonylurea monotherapy compared to metformin monotherapy in a nation-wide cohort
    Reiff, Sascha
    Fava, Stephen
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 147 : 62 - 66
  • [10] Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea
    Ji, L.
    Han, P.
    Liu, Y.
    Yang, G.
    Van, N. K. Dieu
    Vijapurkar, U.
    Qiu, R.
    Meininger, G.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (01): : 23 - 31